Top Markets
Coin of the day
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
株式のランク #25548
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
株価
$20.01
最終同期: 2025-02-21
時価総額
$48.36M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Singular Genomics Systems, Inc. (OMIC)

カテゴリー

Singular Genomics Systems, Inc.(OMIC)のP/B比率
August 2026 時点のP/B比率 TTM: 0.27
Singular Genomics Systems, Inc. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0.27 です。2022 年末時点でのP/B比率は 0.55 でした。
Singular Genomics Systems, Inc. の P/B 比率の履歴(2019 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
2026 (TTM) 0.27 42.74%
2023 0.19 -65.94%
2022 0.55 -77.95%
2021 2.49 -107.20%
2020 -34.58 -52.04%
2019 -72.10 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差
7.6976 2,738.35%
US
1.9116 604.87%
FR
- -
JP
2.0641 661.10%
US
- -
CH